Your browser doesn't support javascript.
loading
T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species.
Grifoni, Alba; Voic, Hannah; Dhanda, Sandeep Kumar; Kidd, Conner K; Brien, James D; Buus, Søren; Stryhn, Anette; Durbin, Anna P; Whitehead, Stephen; Diehl, Sean A; De Silva, Aruna D; Balmaseda, Angel; Harris, Eva; Weiskopf, Daniela; Sette, Alessandro.
Afiliação
  • Grifoni A; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, California, USA.
  • Voic H; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, California, USA.
  • Dhanda SK; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, California, USA.
  • Kidd CK; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, California, USA.
  • Brien JD; Saint Louis University, Saint Louis, Missouri, USA.
  • Buus S; Laboratory of Experimental Immunology, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Stryhn A; Laboratory of Experimental Immunology, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Durbin AP; Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Whitehead S; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Diehl SA; University of Vermont School of Medicine, Burlington, Vermont, USA.
  • De Silva AD; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, California, USA.
  • Balmaseda A; Department of Paraclinical Sciences, General Sir John Kotelawala Defense University, Ratmalana, Sri Lanka.
  • Harris E; National Virology Laboratory, National Center for Diagnosis and Reference, Ministry of Health, Managua, Nicaragua.
  • Weiskopf D; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, California, USA.
  • Sette A; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, California, USA.
J Virol ; 94(10)2020 05 04.
Article em En | MEDLINE | ID: mdl-32132233
ABSTRACT
Members of the flavivirus genus share a high level of sequence similarity and often circulate in the same geographical regions. However, whether T cells induced by one viral species cross-react with other related flaviviruses has not been globally addressed. In this study, we tested pools of epitopes derived from dengue (DENV), Zika (ZIKV), Japanese encephalitis (JEV), West Nile (WNV), and yellow fever (YFV) viruses by intracellular cytokine staining (ICS) using peripheral blood mononuclear cells (PBMCs) of individuals naturally exposed to DENV or immunized with DENV (TV005) or YF17D vaccine. CD8 T cell responses recognized epitopes from multiple flaviviruses; however, the magnitude of cross-reactive responses was consistently severalfold lower than those to the autologous epitope pools and was associated with lower expression of activation markers such as CD40L, CD69, and CD137. Next, we characterized the antigen sensitivity of short-term T cell lines (TCL) representing 29 different individual epitope/donor combinations. TCL derived from DENV monovalent vaccinees induced CD8 and CD4 T cells that cross-reacted within the DENV serocomplex but were consistently associated with >100-fold-lower antigen sensitivity for most other flaviviruses, with no cross-recognition of YFV-derived peptides. CD8 and CD4 TCL from YF17D vaccinees were associated with very limited cross-reactivity with any other flaviviruses and in five out of eight cases >1,000-fold-lower antigen sensitivity. Overall, our data suggest limited cross-reactivity for both CD4 and CD8 T cell responses between flaviviruses and have implications for understanding immunity elicited by natural infection and strategies to develop live attenuated vaccines against flaviviral species.IMPORTANCE The envelope (E) protein is the dominant target of neutralizing antibodies for dengue virus (DENV) and yellow fever virus (YFV). Accordingly, several DENV vaccine constructs use the E protein in a live attenuated vaccine format, utilizing a backbone derived from a heterologous flavivirus (such as YF) as a delivery vector. This backbone comprises the nonstructural (NS) and capsid (C) antigens, which are dominant targets of T cell responses. Here, we demonstrate that cross-reactivity at the level of T cell responses among different flaviviruses is very limited, despite high levels of sequence homology. Thus, the use of heterologous flavivirus species as a live attenuated vaccine vector is not likely to generate optimal T cell responses and might thus impair vaccine performance.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Atenuadas / Vacinas Virais / Vacinação / Infecções por Flavivirus / Reações Cruzadas / Flavivirus Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Virol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Atenuadas / Vacinas Virais / Vacinação / Infecções por Flavivirus / Reações Cruzadas / Flavivirus Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Virol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos